about the historic approval of a CRISPR-based medicine
Published
For the first time, a regulator has cleared a treatment using CRISPR, the gene-editing technology, for patients. The regulator is the United Kingdom’s Medicines and Healthcare products Regulatory Agency. The product is Casgevy, a treatment for sickle cell disease and beta thalassemia, two blood…
#healthcare #crisprtherapeutics #nobel #boston #jenniferdoudna #crispr #african #dewey #crisprcas9 #bcl11aedit